🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
This is a phase II, randomized, double-blind, active-controlled study to ev...
Status
Completed
Location
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Start Date
2019-01-24
Trial ID
NCT03589768
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
The purpose of this study was to assess the safety, effectiveness, and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-14
Trial ID
NCT04886154
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This study aims to evaluate the persistence of anti-poliovirus antibodies i...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-04-25
Trial ID
NCT01323647
Treatments Being Tested
The purpose of this Registry is to detect and describe any abnormal pregnan...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-31
Trial ID
NCT02096276
Treatments Being Tested